Per il presidente di Farma Industria Giorgio Calderari le prospettive del settore sono positive 20 July 2016
Helsinn Group hosts a Satellite Symposium on shared decision making in supportive care, at the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO) Annual Meeting 2016 on June 24th 16 June 2016
Helsinn Group to present at ASCO pooled follow up efficacy data analysis from two Phase III studies for anamorelin in cachectic patients with non-small cell lung cancer (NSCLC) 1 June 2016
Helsinn support the Conquer Cancer Foundation/Anna Braglia Endowed Young Investigator Award in Cancer Supportive Care whit research funding support for promising young physicians 4 May 2016
Helsinn Healthcare SA, The University of Texas MD Anderson Cancer Center enter strategic alliance to improve life of patients conducting clinical studies in cancer supportive and palliative care 26 April 2016
HELSINN GROUP SIGNS EXCLUSIVE AGREEMENT WITH PURDUE PHARMA CANADA FOR THE DISTRIBUTION AND LICENSING RIGHTS OF AKYNZEO® (NETUPITANT/PALONOSETRON combo) IN CANADA 26 April 2016
Linkedin